MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,991,430 | -53.3% | 32,987 | -44.0% | 0.01% | -58.8% |
| Q4 2022 | $17,111,980 | +132.0% | 58,956 | -48.1% | 0.02% | +142.9% |
| Q3 2022 | $7,376,000 | -43.5% | 113,500 | -37.8% | 0.01% | -46.2% |
| Q2 2022 | $13,059,000 | -35.1% | 182,446 | +2.7% | 0.01% | -27.8% |
| Q2 2020 | $20,109,000 | +33.9% | 177,565 | -21.1% | 0.02% | 0.0% |
| Q1 2020 | $15,017,000 | -40.4% | 224,934 | -18.6% | 0.02% | -28.0% |
| Q4 2019 | $25,186,000 | +6.0% | 276,430 | +0.3% | 0.02% | 0.0% |
| Q3 2019 | $23,770,000 | -25.6% | 275,689 | -9.6% | 0.02% | -21.9% |
| Q2 2019 | $31,956,000 | -18.0% | 304,893 | -2.0% | 0.03% | -17.9% |
| Q1 2019 | $38,958,000 | +23.0% | 311,020 | +10.7% | 0.04% | +11.4% |
| Q4 2018 | $31,682,000 | -33.8% | 281,071 | +25.8% | 0.04% | -20.5% |
| Q3 2018 | $47,830,000 | +5.7% | 223,371 | +38.1% | 0.04% | 0.0% |
| Q2 2018 | $45,250,000 | +69.4% | 161,785 | -29.2% | 0.04% | +63.0% |
| Q1 2018 | $26,705,000 | +42.5% | 228,658 | +12.0% | 0.03% | +42.1% |
| Q4 2017 | $18,744,000 | – | 204,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |